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Abstract
Arsenic is a mitochondrial toxin, and its derivatives, such as arsenic trioxide (ATO), can trigger 
endoplasmic reticulum (ER) and the associated unfolded protein response (UPR). Here, we show 
that arsenic induction of the UPR triggers ATF4, which is involved in regulating this ER-
mitochondrial crosstalk that is important for the molecular pathogenesis of arsenic toxicity. 
Employing ATF4+/+ and ATF4−/− MEFs, we show that ATO induces UPR and impairs 
mitochondrial integrity in ATF4+/+ MEF cells which is largely ablated upon loss of ATF4. 
Following ATO treatment, ATF4 activates NADPH oxidase by promoting assembly of the enzyme 
components Rac-1/P47phox/P67phox, which generates ROS/superoxides. Furthermore, ATF4 is 
required for triggering Ca++/calpain/caspase-12-mediated apoptosis following ATO treatment. The 
IP3R inhibitor attenuates Ca++/calpain-dependent apoptosis, as well as reduces m-ROS and MMP 
disruption, suggesting that ER-mitochondria crosstalk involves IP3R-regulated Ca++ signaling. 
Blockade of m-Ca++ entry by inhibiting m-VDAC reduces ATO-mediated UPR in ATF4+/+ cells. 
Additionally, ATO treatment leads to p53-regulated mitochondrial apoptosis, where p53 
phosphorylation plays a key role. Together, these findings indicate that ATO-mediated apoptosis is 
regulated by both ER and mitochondria events that are facilitated by ATF4 and the UPR. Thus, we 
describe novel mechanisms by which ATO orchestrates cytotoxic responses involving interplay of 
ER and mitochondria.
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1. Introduction
Arsenic is a naturally occurring toxic metalloid that is a widespread contaminant in various 
regions of the world [1]. In the environment, arsenic can occur as either inorganic or organic 
forms, with certain inorganic forms being more toxic and persistent [2]. Chronic exposure to 
inorganic arsenic is associated with development of various cancers affecting skin, lungs, 
bladder, colon and liver cancer etc. [3, 4]. Acute exposure of arsenic has been linked to the 
induction of multiple stress signaling pathways, which can trigger cell death in many cell 
types [5].
Both in humans and in experimental animals, sustained activation of cell stress responses 
that can feature oxidative damages, metabolic alterations, and growth inhibition cause 
morbidity and mortality [5, 6]. Arsenic mediated-induction of multiple signaling pathways 
involves increased generation of reactive oxygen species (ROS) that may trigger cell death 
through the mitochondrial regulated signaling pathways. In this regard, we and others have 
shown that arsenic-induced ROS disrupt mitochondrial membrane potential (MMP) and 
mitochondrial functions [7-9], ultimately leading to mitochondrial-regulated cell death [10]. 
In addition, arsenic-mediated endoplasmic reticulum (ER) stress that activates the unfolded 
protein response (UPR) signaling and Ca++ homeostasis imbalances may play a critical role 
in the regulation of cell death [11, 12]. The UPR directs transcriptional and translational 
modes of gene expression that function to ameliorate cell damage and expand the processing 
capacity of the ER [13]. Central to the UPR program of gene expression is the ATF4 
transcription factor that targets genes involved in antioxidation, metabolism, and apoptosis.
Although these stress responses, such as those directed by the UPR, are ubiquitous among 
different tissues, their ultimate effects on viability may be cell-context dependent. For 
example, we recently showed that arsenic trioxide (ATO) activates ER stress and UPR 
signaling in mouse macrophage Raw 264.7 cells, leading to impaired macrophage and innate 
immune functions [14]. In addition to toxicants, mitochondrial dysfunction has also been 
shown to contribute to the pathogenesis of many diseases that feature ER stress. For 
example, Malhotra et al., showed both in vitro and in vivo that misfolding of newly 
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synthesized coagulation factor VIII (FVIII), a protein deficient in hemophilia A, activates 
UPR, which causes oxidative stress and induces apoptosis [15]. Similarly, ER-mitochondria 
pathobiology has been shown to be associated with β-cell dysfunction and peripheral insulin 
resistance in Type 2 diabetes mellitus [16, 17].
In this study, we employed syngeneic ATF4+/+ and ATF4−/− mouse embryonic fibroblast 
(MEFs) and showed that ATO-induced UPR signaling at the ER regulates mitochondrial 
integrity. We found that ATO induces both biochemical and morphological changes in 
mitochondria only in ATF4+/+ cells, whereas ATF4−/− cells remain largely non-responsive to 
ATO. Of importance, ATF4-dependent activation of NADPH oxidase is central for 
augmenting ROS generation. This is done in part through Ca++ release from ER lumen via 
inositol trisphosphate receptor (IP3R) phosphorylation. Thus, blocking Ca++ release by Ca++ 
channel blockers or Ca++-specific chelators attenuates ATO-mediated toxicity. ATF4 also 
regulates mitochondrial responses via regulation of the voltage-dependent anion channel 
(VDAC), which is involved in Ca++-directed MMP regulation and production of 
mitochondrial ROS (mROS). Attenuation of VDAC-regulated responses restores ER-
regulated UPR signaling. Together, this study indicates that ATF4 is required for ATO-
mediated alterations in ER–mitochondrial crosstalk via Ca++ homeostasis.
2. Materials and methods
2.1. Cell culture and treatments
ATF4+/+ and ATF4−/− MEF cells were cultured in the presence of 1% non-essential amino 
acid and 50 μM β-mercaptoethenol in DMEM medium at 370C in a CO2 incubator. MEFs 
were exposed to either saline (control) or ATO at concentrations (1-10 μM) for up to 24 h. 2-
aminoethyl diphenylborinate (2-APB) (20 μM, 6 h), 4-phenylbutyric acid (4-PBA) (1 mM, 6 
h), BAPTA-AM (5 μM, 6h), 4-chlorophenoxy) acetamide, trans-N,N′-1,4-
cyclohexanediylbis[2-(4-chlorophenoxy)-acetamide (ISRIB) (200 nM, 6h), superoxide 
dismutase (SOD) (50 unit/ml), MnTABP (50μM, 6h), 4, 4’-diisothiocyano-2,2'-
stilbenedisulfonic acid (DIDS) (200 μM, 6h), thapsigargin (TG) (2.5 M, 3 h), and 4’-
hydroxy-3’-methoxyacetophenone (apocynin) (100 μM, 6 h) were used as a pre-treatment in 
cell culture studies.
2.2. MTT assay
ATO concentrations for this study were selected on the basis of their effects on cell viability 
in MTT assays. ATO-treated cells were washed with PBS and incubated with MTT (0.5 
mg/ml) (Sigma, St. Louis, MO) dye for 3 h at 37°C. At the end of incubation period, the 
reaction mixture was replaced with 200 l of dimethyl sulfoxide and plates were read at 490 
nm using 1420 multilable counter VICTOR3 (Perkin Elmer, Shelton, CT) as described [14]. 
Saline-treated sets of cells were also run under identical conditions and served as basal 
control.
2.3. Morphological changes
Morphological changes were assessed in either saline or ATO-treated cultured MEFs and 
observed for any phenotypic alterations such as cell roundness, cell adhesion loss, and cell 
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blebbing. Cells were visualized by a Olympus BX51TRF microscope and images were 
obtained using an Olympus DP71 digital camera (Tokyo, Japan).
2.4. Fractional studies
Cytoplasmic and mitochondrial fractions from ATF4+/+ and ATF4−/− MEFs was prepared as 
described [18]. Briefly, harvested cells were suspended in ice-cold cell homogenization 
medium (150mM MgCl2, 10mM Kcl, 10mM Tris.Cl, pH-6.7). After homogenization, nuclei 
were pelleted by centrifugation for 5 min at 1000xg. Supernatant was then subjected to 
centrifugation at 5000xg to isolate mitochondria. Mitochondrial pellet was suspended in 
mitochondrial suspension medium (0.25M sucrose, 10mM Tris-base, pH 7) and processed 
for protein quantification and western blot analyses.
2.5. Immunofluorescence staining
Following ATO treatment, MEFs were washed with PBS, fixed in 4 % paraformaldehyde, 
and permeabilized with 0.1% Triton X-100. Cells were blocked for 1 h with 2% bovine 
serum albumin. Cells were then incubated with the following primary antibodies: Rac-1 
(1:100, Santa Cruz, SC-95), ATF4 (1:100 Cell Signaling-11815), CHOP (1:100, Cell 
Signaling-2895) or cytochrome-c (1:100, Santa Cruz, SC-13156) overnight at 4°C. After 
PBS washes, cells were incubated with fluorescein-conjugated secondary antibodies for 
1-1.5 h at room temperature. Labeled cells were visualized by fluorescence microscopy 
(Olympus1X-S8F2, Japan) or confocal microscopy (Zeiss LSM 710 confocal software 63X 
water corrected objective). In some experiments, cells were stained with mitotracker red 
(Sigma, St. Louis, MO) or wheat germ agglutinin dye (Invitrogen, Carlsbad, CA) before 
fixing to stain mitochondria or plasma membrane, respectively.
2.6. Cellular reactive oxygen species (ROS)/superoxide detection
ROS levels were measured by using DCFH-DA probe and the cellular ROS/superoxide 
assay kit (Abcam, Cambridge, MA). The Abcam ROS/superoxide assay kit includes two 
fluorescent dyes, which are designed to detect oxidative stress by fluorescent detection 
reagent (green) for overall ROS and superoxide (O2−) generation by specific fluorescent 
reagents. We employed two different methods for recording ROS/O2− radicals that were 
assayed by ELISA-based plate reader assay and fluorescence-based microscopic image 
analysis. These experiments incorporated inhibitors of O2− radicals, including SOD and 
SOD mimic, MnTABP, as indicated. For ELISA-based assays, 10,000 cells/well were seeded 
onto 96-well black bottom plates. Following ATO treatment with or without SOD or 
MnTABP, cells were washed with PBS and labeled with O2− detection reagent for 30 min 
according to the manufacturer's instructions. Mean fluorescence intensity of O2− radicals 
was recorded at Ex/Em = 550/620 nm and presented as percent change compared to control. 
For microscopic image analysis, 30,000 cell/well were grown on a coverslip. Following 
various treatments, cells were washed with PBS and labeled with O2− detection reagent for 
30 min at 37 °C. Cells were washed again with PBS and visualized by fluorescent 
microscopy (Olympus1X-S8F2, Japan).
Similarly, overall ROS were detected using DCFH-DA probe by both ELISA-based plate 
reader assay and microscopic analysis. Following ATO treatment with or without NADPH 
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oxidase inhibitors apocynin, MEFs were washed with PBS and labeled with DCFH-DA 
probe. Mean fluorescence intensity was recorded at Ex/Em= 485/535 nm and presented as 
percent change compared to control. Saline-treated sets were also run in parallel under 
identical conditions and served as controls.
2.7. Mitochondrial ROS (mROS)
mROS was assessed by the Elite™ mitochondrial ROS activity assay kit (eEnzyme, 
Gaithersburg, MD). Elite™ ROS orange is a membrane permeable non-fluorescent ROS 
sensor that rapidly penetrates into mitochondria and generates very strong fluorescence 
signals upon reacting with O2− or hydroxyl radicals. Using this kit, mROS was measured by 
using a ELISA-based plate reader assay, as well as through fluorescent image analysis. 
Briefly, for plate reader assays, cells were seeded onto 96-well black bottom plates at 
density 10,000 cells/well. Following the indicated stress treatments, MEFs were labeled with 
Elite™ mROS orange stain for 30 min at 37 °C as described in the manufacturer's 
instruction manual. Fluorescence intensity was measured at Ex/Em=540/570 nm. As 
controls, saline-treated sets were also analyzed during identical conditions.
Image analysis for mROS production in cells grown on a cover slip was performed using 
fluorescence microscopy. Following the indicated treatments, cells were washed with PBS 
and labeled with Elite™ ROS orange stain for 30 min at 37 °C. Cells were washed again 
with PBS and visualized under fluorescent microscope equipped with TRITC filter set.
2.8. Detection of Ca++ levels
Fluo-4 direct calcium assay kit was used to determine intracellular Ca++ levels in saline vs. 
ATO (2 & 5μM, 14h)-treated MEFs following the instructions provided by the manufacturer 
(Invitrogen, Carlsbad, CA). Fluorescence at excitation wavelength 494 nm and 516 nm was 
recorded and expressed as relative fluorescence intensity (RFU). Additionally, image 
analysis of Ca++ release was performed according to manufacturer instruction using 
fluorescence microscopy.
2.9. Mitochondrial membrane potential (MMP)
MMP was detected using a cationic dye JC-1 (Sigma, St. Lousi, MO). In intact 
mitochondria, JC-1 forms aggregates and emit red fluorescence, whereas loss of MMP leads 
to accumulation of JC-1 monomer that emit green fluorescence. After various treatments, 
cells were incubated with JC-1 dye (10 μM) for 15 min at 37°C followed by PBS wash. 
Cells were imaged and analyzed with fluorescence microscopy to assess changes in the ratio 
of red to green fluorescence.
2.10. Transmission Electron Microscopy (TEM)
TEM analysis was performed as described earlier [19]. In brief, ATF4+/+ and ATF4−/− MEFs 
were treated with ATO and then fixed with 2% paraformaldehyde and 2.5% glutaraldehyde 
in a solution of 0.1 M cacodylate buffer. Cells were then placed in a ice-cold solution of 1% 
osmium tetraoxide (EMS, Hatfield, PA), 0.8% potassium tetraoxide, and 3 mM calcium 
chloride. Ultrathin sections were prepared using a Reichert-Ultracut E ultramicrotome and 
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supported on copper grids/75 mesh, followed by Sato lead stain. Stained sections were 
imaged using a Tecnai Spirit Twin 20-120 kv electron microscope (FEI, Hillsboro, OR).
2.11. Protein quantification and western blot analysis
Protein assays were carried out using a DC kit (Bio-Rad, Hercules, CA). Equal amounts of 
protein in whole cell lysates were mixed with 4X laemmli sample buffer (Bio-Rad, Hercules, 
CA), boiled for 5 minute at 95°C, and resolved by SDS-PAGE. Proteins were then 
electrophoretically transferred to polyvinylidene difluoride (PVDF) membranes and 
incubated with primary antibodies i.e. GRP78 (1:1000, Cat no. 3177), GRP94 (1:800, Cat 
no. 20292), p-PERK (1:1000, Cat no. 3179), ATF4 (1:1000, Cat no. 11815), CHOP (1:1000, 
Cat no. 2895), p-eIF2α (1:1000, Cat no. 3398), t-eIF2α (1:1000, Cat no. 5324), p-IP3R 
(1:800, Cat no. 8548), cleaved caspase-3 (1:1000, Cat no. 9661), calpian-1 (1:1000, Cat no. 
2556), cleaved caspase-12 (1:800, Cat no.2202), Rac-1 (1:500, Cat no. SC-95), P47phox 
(1:500, Cat no. SC-14015), P76phox (1:1000, Cat no. 3923), GRP75 (1:1000, Cat no. 3593), 
Bax (1:1000, Cat no. 2772), Cytochrome C (1:1000, Cat no. 4272), p-p53 (1:1000, Cat no. 
9286), p53 (1:1000, Cat no. 2527), VDAC (1:1000, Cat no. 4866), α-β tubulin (1:1000, Cat 
no. 2148), β- actin (1:5000) p-DRP-1 (S616, Cat no. 4494) ,or pDRP-1 (S637, Cat no. 4867) 
(1:1000 dilution) for overnight at 4°C. All the antibodies for western blots were purchased 
from Cell signaling technology (Danvers, MA), except for the preparation against β-actin 
(Sigma, St. Louis, MO), Rac-1 and P47phox (Santa Cruz, Dallas, TX). Membranes were 
washed and then incubated with HRP conjugated secondary antibody. Blots were developed 
with enhanced chemiluminescence according to manufacturer's instructions (Amersham 
Bioscience, Piscataway, NJ).
2.12. Statistical analysis
Data are expressed as mean ± standard error of mean (SEM). Data were analyzed for 
statistical significance using one-way analysis of variance (ANOVA) followed by either 
Dunnett's or Bonferroni post-hoc test to compare multiple groups. The statistical analyses 
were performed using GraphPad Prism 7. P<0.05 was considered to be statistically 
significant. *- significant compared to controls. # - significant compared to ATO.
3. Results
3.1. ATO alters cell viability in a ATF4-dependent manner
ATF4+/+ and ATF4−/− MEF cells show the expected differences in genetic ablation for this 
transcription factor (Fig. 1A). To determine the suitable ATO doses and exposure times for 
altered cells viability, we conducted MTT assays at concentrations (1-10 μM) of ATO for 24 
h (Supplementary Fig. S1). From this MTT data, we selected 2 and 5 μM concentrations of 
ATO, which had significant differential viability effects on these MEF cells. While these 
concentrations manifested multiple morphological and molecular alterations in ATF4+/+ 
MEFs, the ATF4-deficient (ATF4−/−) cells were resistant. Phenotypic changes observed by 
ATO treatments included cell rounding, loss of cell adhesion, and blebbing, which were 
readily visible at 24 h (Fig. 1B). These findings demonstrated that ATO impairs cell viability 
and morphological alterations in ATF4+/+ cells in a concentration-dependent manner, 
whereas ATF4−/− cells were resistant to these effects of ATO.
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3.2. ATO-induced ROS/superoxide generation requires ATF4 and is regulated by the 
activation of NADPH-oxidase
Superoxide anions are generated in cells by both enzymatic and non-enzymatic mechanisms 
and are known to play an important role in tissue injury [20]. Our immunofluorescence and 
ELISA-based assays showed that ATO induces superoxide radicals more efficiently in 
ATF4+/+ as compared to ATF4-depleted cells (Fig. 1C.I & 1C.II). Generation of O2− 
following ATO exposure could be blocked by treating cells with permeable SOD or SOD 
mimetic, MnTABP (Fig. 1D), demonstrating specificity of the assay. These results further 
demonstrate that ATO-induced ROS/superoxide production occurs primarily through the 
activation of NADPH oxidase complex in ATF4+/+ but not in ATF4-depleted cells.
NADPH oxidase consists of three cytosolic components (p67phox, p47phox and p40phox), two 
membrane-bound elements (gp91phox and p22phox), and a low-molecular-weight G protein 
(Rac-1) [21]. Activation of NADPH oxidase requires translocation of the cytosolic 
components to plasma membranes. ATO treatment induced expression of NADPH oxidase 
complex subunits P47phox, P67phox and Rac-1 (Fig. 1E.I & 1E.II). ATO also triggered 
translocation of Rac-1 from the cytosol to plasma membranes, resulting in the formation of 
catalytically active NOX complex (Fig. 1F). These ATO-mediated changes occurred in 
ATF4+/+ cells, but not in those deficient for the transcription factor. Pretreatment with 
apocynin, an inhibitor of NADPH oxidase significantly reduced ROS generation in ATF4+/+ 
MEFs treated with ATO (Supplementary Fig. S2), suggesting that the early response of ATO 
to induce ROS may be mediated by activation of NADPH oxidase pathway. These results 
demonstrate the importance of ATF4 in ATO-mediated ROS/superoxide production.
3.3. ATO-induced UPR signaling is ATF4-dependent
Following ER stress, ATF4 translocates to the nucleus and initiates the transcription of UPR 
target genes, including genes encoding additional transcription factors, such as CHOP 
(GADD153/DDIT3) [23]. Employing immunofluorescence staining of ATF4 and its 
downstream target CHOP, we determined that both transcription factor translocate from the 
cytoplasm to nucleus in ATF4+/+ MEFs (Fig. 2A & 2B). As expected detection of these 
transcription factors were much diminished in the ATF4-deleted cells. In the UPR, PERK 
phosphorylation of eIF2α leads to inhibition of protein synthesis and increased translational 
expression of the transcription factor ATF4 and associated downstream signaling events 
[24]. Our data confirm that ATO treatment induces p-PERK, GRP78, GRP94, p-eIF2α, and 
CHOP largely in an ATF4-dependent manner (Fig. 2C.I & 2.C.II). However, following 
treatment of ATF4−/− MEFs with ATO, the induction of p-eIF2α and CHOP was slightly 
higher than their respective controls but not as significant as those found in ATO-treated 
ATF4+/+ MEFs. We realize that this slight increase may be indicative of upregulation of 
additional pathways by ATO. To confirm the role of PERK in ATO-mediated UPR signaling 
we used ISRIB. ISRIB is a potent inhibitor of PERK signaling by thwarting the ability of 
eIF2α phosphorylation to trigger global and gene-specific translational control in the UPR 
[25]. As expected, we found that pharmacological inhibition of the PERK arm of the UPR 
significantly reduced ATO-induced nuclear translocation of ATF4 (Fig. 2D.I). In addition, 
we confirmed that ATO-induced CHOP expression was reduced by ISRIB treatment (Fig. 
2D.II). Furthermore, UPR inhibitor 4-PBA, attenuated the expression of these proteins, 
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whereas ER stress inducer thapsiagargin (TG) augmented these effects (Fig. 2E.I & 2E.II). 
These finding highlight the roles of PERK and ATF4 in the UPR activated by ATO.
3.4. ATF4 is required for ATO-induced ER-mitochondria-mediated apoptosis
Since, ER-stress and mitochondria-regulated signaling pathways represent major pathways 
for apoptosis, we investigated further the role of ATF4 in the regulation of both of these 
pathways in cell death. Previously it was reported that activation of IP3R on the ER 
membrane induces Ca++ release from ER to cytosol [26]. The increased cytosolic Ca++ 
induces Ca++/calpain-dependent signaling, leading to apoptosis [27]. Mitochondrial 
chaperone GRP75 has also been shown to regulate IP3R-mediated mitochondrial Ca++ 
signaling via VDAC [28]. Employing the ATF4+/+ and ATF4−/− MEFs, we determined that 
ATO treatment induces p-IP3R and GRP75 (Fig. 3A), intracellular Ca++ release (Fig. 3B.I & 
3B.II), and expression of calpain-1, cleaved caspase-12, and cleaved caspase-3 (Fig. 3C.I & 
C.II) specifically in the cells expressing ATF4. These effects could be inhibited by 4-PBA, a 
chemical chaperone reported to relieve ER stress, and be augmented by TG treatment (Fig. 
3D). To further address the role of Ca++ in ATO-mediated cell death, we used a cell 
permeable calcium chelator, BAPTA-AM [30]. Our results demonstrated that pretreatment 
of BAPTA-AM significantly blocked ATO-induced cell death in the ATF4+/+ MEFs (Fig. 
3E). Furthermore, we observed that ATO not only invokes ER stress-regulated Ca++/calpain-
mediated apoptosis but also triggers mitochondrial-mediated apoptosis as ascertained by p-
p53 (Fig. 4A.I and 4A.II), mROS production (Fig. 4B, Supplementary Fig. S3) and loss of 
MMP integrity (Fig. 4C). These signals can result in the leakage of cytochrome c from 
mitochondria to cytoplasm and Bax translocation from cytoplasm to mitochondria in ATF4-
dependent manner (Fig. 4D). These results were also confirmed by high resolution confocal 
microscopy (Fig. 4E).
It is known that a balance of mitochondrial fission and fusion can regulate many 
mitochondrial functions [19]. In this regard, ATO-treatment of ATF4+/+ MEFs induced 
phosphorylation of dynamin-related protein (DRP1) at Ser 637, and decreased 
phosphorylation at Ser 616 (Fig. 5A). Drp1, a GTPase family proteins, is associated with 
several important functional aspects of mitochondria in mammalian cells which include 
shape and size, distribution, remodeling, and maintenance [31]. In this regard, ATO also 
induced ultra-structural changes in mitochondria as determined by TEM analysis. The well-
defined double membrane structure with high cristae density of mitochondria found in 
saline-treated control cells (Fig. 5B, panels 1, 2 & 3), were altered in ATO-treated ATF4+/+ 
MEFs (5B, panels 4, 5 & 6). It is also noted that the mitochondria were partially or fully 
devoid of cristae and showed loss of double membrane structures in response to ATO 
treatment (Fig. 5B, panels 5 & 6). However, no significant changes in the ultra-structural 
morphology of mitochondria could be seen in saline-treated vs. ATO-treated ATF4−/−MEFs 
(Fig. 5C, panels 1, 2 & 3 show saline-treated cells and panel 4, 5 & 6 show ATO-treated 
ATF4−/− cells). Similarly, the proximal organization of ER and mitochondria was also 
altered in the ATO challenged ATF4+/+ cells (Fig. 5D).
In summary, these experiments demonstrate that ATF4 is required for ATO-mediated 
alterations in both the ER and mitochondria. These results also confirm that ATO-initiated 
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signals related to protein folding at the ER are important for regulating mitochondrial 
functions, which can culminate in the control of cell death.
3.5. ATF4 regulates ER-mitochondrial crosstalk following ATO treatment
Previous studies have shown the important effects of arsenic on ER/mitochondrial–mediated 
apoptosis [8, 11, 12, 32]. However, the role of ATF4 in linking arsenic-mediated ER-
mitochondrial crosstalk and -associated cell death were not defined. Our experiments 
demonstrate that pretreatment of ATF4+/+ MEFs with 2-APB, an IP3R channel blocker 
attenuates ATO-induced phosphorylation of IP3R (Fig. 6A). In addition, 2-APB reduces the 
ER-regulated Ca++/calpain-1/caspase-12-mediated apoptosis (Fig. 6B) and mitochondrial 
damage, as determined by the restoration of MMP and diminution of mROS generation in 
ATF4+/+ MEFs (Fig. 6C). Selection of 2-APB in this study was based on a previous report 
that 2-APB attenuated NMDA-triggered intracellular Ca++ increases by blocking IP3R 
channels and ER stress during neuronal cell death [33]. Furthermore, we also investigated 
whether VDAC channel inhibitor DIDS, which is known to inhibit Ca++ influx into 
mitochondria [34], affects ATO toxicity. Pretreatment of ATF4+/+ cells with DIDS 
diminished not only the alterations in MMP and mROS production (Fig. 6C) but also 
thwarted ATO-induced UPR activation (Fig. 6D.I & 6D.II). Interestingly, ISRIB was also 
found to restore ATO-induced Ca++ release (Supplementary Fig. S4) and associated MMP 
loss as ascertained by JC-1 dye (Fig. 6E). These results support the importance of ER-
mitochondria crosstalk in the toxicity of arsenic through a mechanism requiring ATF4.
Discussion
Arsenic is globally distributed toxic metalloid and environmental pollutant [1]. Both in vitro 
and in vivo studies have shown that arsenic can induce higher production of ROS, prompting 
oxidative stress-induced cell damage and subsequent cell death [35, 36]. Recent studies have 
demonstrated that arsenic-induced oxidative stress has been linked to cell death signaling 
pathways that include mitochondrial-mediated cell death and ER-regulated cell death [11, 
37]. However, the mechanisms regulating these cell death pathways in arsenic toxicity were 
poorly understood. We show that ATF4 orchestrates the crosstalk between ER and 
mitochondria as an underlying mechanism of arsenic toxicity. We also demonstrate that 
ATO-mediated ROS generation is dependent on ATF4.
For these studies we have employed a variety of fluorescent probes. In this regard, DCFH-
DA is a widely used probe for detecting intracellular ROS generation in live cells [38]. After 
passive diffusion into the cell, DCFH-DA is deacetylated by cellular esterases and is 
oxidized by ROS into 2’, 7’ –dichlorofluorescein (DCF) which could be detected by 
fluorescence-based techniques. Nonetheless, use of DCFH-DA is also associated with some 
artifacts and limitations [39]. For example, direct oxidation of DCFH to DCF by oxidases or 
cytochrome c could lead to false signal [40-43]. Therefore, our data with DCFH-DA was 
confirmed with other commercially available ROS/superoxide detection kits. This minimizes 
the artifacts particularly in the presence of negative controls and various inhibitors. Thus, 
our data demonstrating that ATO induces O2− radical generation in an ATF4-dependent 
manner involves multiple approaches and supports earlier reports that arsenic induces ROS 
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[4, 44]. Importantly, we identified NADPH oxidase as the source of ROS generation in cells 
following ATO insult. ATO-dependent activation of NADPH oxidase requires translocation 
of the p47phox, p67phox and Rac1 cytoplasmic proteins to plasma membranes via 
transcriptional activation of ATF4 as cells devoid of this transcription factor did not show 
this enzyme assembly. These findings also complement and confirm earlier results showing 
that ATF4−/− MEFs following ER or other cellular stress are unable to induce expression of 
GADD34, a UPR gene associated with cell death following ER stress [45].
CHOP, a gene induced downstream of ATF4 in the UPR, can induce apoptosis during 
specific ER stress conditions. Sustained activation of CHOP is critical to induce apoptosis 
[46]. Since we observed that arsenic induces CHOP expression through the PERK/ATF4-
dependent pathway, observed apoptosis of ATF4+/+ MEFs is suggested to feature induction 
of CHOP. However, CHOP also increases ER oxidase 1α (Ero1α) expression, which 
stimulates calcium release from IP3R on the ER membrane favoring ER Ca++ release to 
cytosol [47]. Therefore, additional mechanisms involving CHOP activation may also 
contribute to the toxic manifestations of arsenic. Activation of Ca++/calpain-dependent 
signaling, together with mitochondrial p53-regulated signaling, (Fig. 3 & 4) suggest an 
important linkage between mitochondrial and cytosolic cell death signaling pathways 
through processes requiring ATF4.
In summary, blocked IP3R-regulated Ca++ release, or reduced mitochondrial Ca++ uptake 
via VDAC inhibition, can attenuate increases in MMP and mROS production and restore 
cell survival. The findings support the idea that there is an important role of ER-
mitochondrial crosstalk in arsenic-mediated toxicity. Our observations that arsenic-induced 
mitochondrial damage suggest a requirement for this transcription factor in evoking 
mitochondrial damage and transducing mitochondria-regulated death signals. Further, these 
studies underscore the importance of ATF4 in the pathogenesis of arsenic toxicity.
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Highlights
• ATO-mediated NADPH oxidase complex formation and activation 
require ATF4.
• ATO-mediated dysregulation of Ca++ homeostasis is ATF4 dependent.
• ATO-mediated alterations in mitochondria are ATF4 dependent.
• ER-mitochondrial crosstalk in the toxicity of ATO is regulated by 
ATF4.
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Figure-1. ATO-induced ROS requires ATF4 through activation of NADPH oxidase
(A) Western blot analysis of ATF4 in MEFs. (B) Bright field images of saline (control) and 
ATO-treated MEFs. ATO-treated cells (5μM, 14h) showing changes in cell rounding, loss of 
cell adhesion, and blebbing in ATF4+/+ MEFs (black arrows) but not in ATF4−/−. (C.I) Mean 
fluorescence intensity showing percent change in O2− radicals generation in control vs. 
ATO-treated ATF4+/+ and ATF4−/− MEFs. (C.II) Fluorescence images of superoxide radicals 
(Red) in ATF4+/+ and ATF4−/− MEFs treated with either saline (control) or ATO. (D) 
Fluorescence images of ATO-induced superoxide radicals in the absence or presence of SOD 
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(50 unit/ml, 6 h) or MnTABP (50 μM, 6 h) in ATF4+/+ MEFs. O2− generation was measured 
using ROS/superoxide assay kit (Abcam). (E.I) Western blot expression analysis of P67phox, 
P47phox and Rac-1 in ATF4+/+ and ATF4−/− MEFs. (E.II) Histogram showing densitometry 
analysis of western blots. (F) Immunofluorescence staining of Rac-1 in ATF4+/+ and 
ATF4−/− MEFs. Arrows indicating the translocation of Rac-1 (green) from cytoplasm to the 
plasma membrane (Red) in ATO-exposed ATF4+/+ MEFs. These effects were not observed 
with ATF4−/− MEFs. Plasma membrane was stained with WGA-conjugated Alexa fluor-594. 
*P<0.05, **P<0.01, ***P<0.001, ***P<0.0001 compared to their respective controls. NS- 
Non significant compared to their respective controls.
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Figure-2. ATO-induced UPR activation requires ATF4
(A & B) Immunofluorescence staining showing nuclear localization of ATF4 (A) and CHOP 
(B) in ATO-treated ATF4+/+ MEFs compared to saline-treated control cells. ATF4−/− MEFs 
showed resistance to ATO. Arrows indicate nuclear translocations. Nuclei were stained with 
DAPI. (C.I) Western blot analyses of UPR signaling proteins p-PERK, GRP78, GRP94, p-
eIF2α, t- eIF2α and CHOP in ATF4+/+ and ATF4−/− MEFs. (C.II) Histogram showing 
densitometric analysis of western blots. (D.I) Pretreatment of ISRIB (250 nM, 6h) 
significantly blocked ATO-induced nuclear translocation of ATF4 protein in MEFs. (D.II) 
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Western blot analysis of ATO-induced p-PERK and CHOP in cells pretreated with ISRIB. 
(E.I) Western blots analysis of GRP78, GRP94, p-eIF2α, total eIF2α, and CHOP in ATF4+/+ 
MEFs pretreated with 4-PBA (1mM) or TG (2.5μM) for 6 h, followed by ATO exposure for 
14 h. (E.II) Histograms showing densitometric analyses of western blots. β-actin was used as 
endogenous control. *P<0.05, **P<0.01, ***P<0.001 compared to their respective 
controls. #P<0.05 compared to ATO. NS- Non significant compared to their respective 
controls.
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Figure-3. ATO-induced Ca++/calpain-mediated apoptosis is regulated by ATF4
(A) Western blot expression of p-IP3R and GRP75 in either saline-treated (control) or ATO-
treated ATF4+/+ and ATF4−/− MEFs. Protein levels were normalized to endogenous control 
β-actin and represented as fold change of the indicated proteins. (B.I) Images of ATF4+/+ 
and ATF4−/− MEFs showing intracellular Ca++ release from MEFs treated with either saline 
or ATO (2 & 5 μM, 14 h). (B.II) Histograms showing intracellular Ca++ release from 
ATF4+/+ and ATF4−/− MEFs. Calcium ionophore-A23187 (Ca. Iono.) (2 μM, 3 h) was used 
as positive control. (C.I) Western blot analyses of calpain-1, cleaved caspase-12 and cleaved 
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caspase-3 in the cell lysate prepared from MEFs treated with ATF4 or saline (C.II) 
Histogram showing densitometric analyses of western blots. (D) Western blot measurements 
of cleaved caspase-12 and cleaved caspase-3. ATF4+/+ MEFs were pretreated with 4-PBA 
(1mM) or TG (2.5 μM) for 6 h, followed by ATO exposure for 14 h. (E) Percent cell 
viability assessed by MTT assays. ATO led to decreased cell viability, which was 
significantly rescued by pretreatment with BAPTA-AM (5 μM, 6 h). *P<0.05, **P<0.01, 
***P<0.001, ***P<0.0001 compared to their respective controls. ###P<0.0001 compared to 
ATO. NS- Non significant compared to their respective controls.
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Figure-4. ATO-induced mitochondrial-mediated apoptosis in an ATF4-dependent manner
(A.I) Western blot analyses of phosphorylated p53 (p-p53) and total p53 in ATF4+/+ and 
ATF4−/− MEFs treated with ATO or saline. (A.II) Histograms showing densitometric 
measurement of western blots. (B) Mean fluorescence intensity showing percent changes in 
mROS generation in saline (control) vs. ATO-treated (5 μM, 14 h) MEFs using Elite™ 
mROS activity assay kit. (C) Alteration in mitochondrial membrane potential was assessed 
using the fluorescent cationic dye, JC-1 (10 μM, 15 min) as assessed by the changes in the 
ratio of red (dye aggregates) to green (monomer) forms under a fluorescence microscope in 
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control vs. ATO-treated (5 μM, 14 h) ATF4+/+ and ATF4−/− MEFs. (D) Western blot analysis 
of ATO-induced release of cytochrome c (cyto c) from mitochondria to cytoplasm and 
translocation of Bax from cytoplasm to mitochondria. Fraction purity was confirmed by α/
β-tubulin and VDAC for cytoplasmic and mitochondrial fractions respectively. (E) Confocal 
images of immunofluorescence staining showing release of cytochrome c from mitochondria 
to cytoplasm in MEFs. ATO-treatment (5 μM, 14 h) releases cytochrome c from 
mitochondria to cytoplasm (marked by arrows) in ATF4+/+ MEFs, whereas ATF4−/− cells 
showed significantly diminished release. **P<0.01, ***P<0.01 compared to their respective 
controls. NS- Non significant compared to their respective controls.
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Figure-5. ATO-induced ultrastructural changes in mitochondria are regulated by ATF4
(A) Western blot analyses of phosphorylated-DRP1 (p-DRP1) at S637 and S616 in ATF4+/+ 
and ATF4−/− MEFs. Protein levels were normalized to endogenous control β-actin and were 
represented as fold changes. (B & C) Saline and ATO (5 μM, 14 h)-treated MEFs were 
processed for transmission electron microscopic analysis to assess ultra-structural changes in 
mitochondrial morphology. (B) Panel 1, control ATF4+/+ MEFs shows well-maintained 
morphology of mitochondria. Panel 2, showing well-organized cristae density. Panel 3, 
enlarged image showing well-organized inner and outer membranes of mitochondria. Panel 
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4, ATO-treated ATF4+/+ MEFs shows damaged mitochondria with condensed nuclear 
material. Panel 5 illustrates elongated mitochondria with the loss of cristae structure, panel 6 
showing loss of double membrane structure of mitochondria. (C) Panels 1, 2 and 3 
( enlarged image) shows control ATF4−/− MEFs. Panels 4, 5 and 6 (enlarged image) are 
ATO-treated ATF4−/− MEFs. M, represents mitochondria and ER, indicates endoplasmic 
reticulum. (D) Morphometric analyses quantifying average distance between ER and 
mitochondria in ATO-treated and non-treated ATF4+/+ and ATF4−/− MEFs. ** P<0.001 
show significant level. NS- Non significant
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Figure-6. ATF4 promotes ER-mitochondrial crosstalk following ATO treatment
(A & B) Western blot analysis showing levels of p-IP3R, calpain-1, cleaved caspase-12, and 
cleaved caspase-3 proteins in ATO (5μM, 14h)-treated ATF4+/+ cells pretreated with either 
vehicle saline or 2-APB, an IP3R inhibitor. Protein levels were normalized to endogenous 
control β-actin and represented as fold changes. (C) Alterations in mitochondrial membrane 
potential and mROS was assessed using a fluorescent cationic dye, JC-1 (10μM, 15min) and 
Elite™ mROS activity assay kit respectively. Blocking of IP3R and VDAC channel by 
pretreating ATF4+/+ cells with 2-APB or DIDS respectively attenuated ATO-induced MMP 
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and mROS in ATF4+/+ cells. (D.I) Western blot analyses show pretreatment of ATF4+/+ 
MEFs with DIDS reduced the ATO-induced UPR signaling proteins p-PERK, p-eIF2α, 
ATF4, CHOP, and p-IP3R. (D.II) Histograms showing measurements of proteins analyzed 
by western blots. (E) MMP was monitored using a fluorescent cationic dye, JC-1 (10 μM, 15 
min) as assessed by the changes in the ratio of red (dye aggregates) to green (monomer) 
forms under the fluorescence microscope. These cells were treated with saline (control) or 
ATO (5μM, 14 h) or ATO in ISRIB (250nM, 6h) pretreated cells. *P<0.05, **P<0.01, 
***P<0.001 compared to their respective controls. #P<0.05, ##P<0.01, ###P<0.001 compared 
to ATO.
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